Hypofractionated Breast Radiotherapy for 1 Week versus 3 Weeks (FAST-Forward): 5-Year Efficacy and Late Normal Tissue Effects; Results from a Multicentre, Non-Inferiority, Randomised, Phase 3 Trial
Haris PA., Dodwell D.
This study aimed to identify a five-fraction schedule of adjuvant radiotherapy delivered in 1 week that is non-inferior in terms of local cancer control and is as safe as an international standard 15-fraction regimen after primary surgery for early breast cancer.